In addition, Biosearch will manufacture cGMP oligonucleotides for IMDx for use in human in-vitro diagnostics.

Biosearch is a supplier of oligonucleotide components to the molecular diagnostics industry and IMDx is a developer and manufacturer of clinically impactful molecular test solutions.

Biosearch Technologies Corporate Development director Marc Beal said IMDx’s assays, powered by BHQ probing technologies, provides a potent combination for future diagnostic tests.

IMDx chairman and CEO Alice Jacobs said they are pleased to be working with Biosearch and believe BHQ probes are very effective, leading to highly differentiated products for many markets.